Women are more likely to live in ill health, spending 25 percent more of their lives in this state compared to men, highlighting the deep-rooted gender health gap.
When women seek treatment, they often face longer waits and their pain is less frequently assessed, showcasing systemic sexism in healthcare.
Clinical trials are predominantly conducted on men, resulting in drugs that may not work effectively for women and may come with unpredictable side effects.
The McKinsey Health Institute estimates that recognizing and addressing the gender health gap could significantly benefit economies, potentially increasing the UK economy by £39 billion.
Collection
[
|
...
]